HEPION PHARMACEUTICALS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
HEPION PHARMACEUTICALS, INC. (HEPA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $900.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-12
- HEPION PHARMACEUTICALS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $900.00K, a 0.00% change from fiscal 2024.
- HEPION PHARMACEUTICALS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $900.00K, a 93.28% decline from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $13.40M, a 10.74% increase from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $12.10M, a 37.50% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $900.00K 10-K · filed 2026-03-12 | ||
| 2024-12-31 | $900.00K 10-K · filed 2026-03-12 | $13.40M 10-K · filed 2025-04-08 | |
| 2023-12-31 | $13.40M 10-K · filed 2025-04-08 | ||
| 2022-12-31 | $12.10M 10-K · filed 2024-04-16 | ||
| 2021-12-31 | $8.80M 10-K · filed 2023-04-10 | ||
| 2020-12-31 | $2.50M 10-K · filed 2022-04-08 | $5.90M 10-K · filed 2021-03-31 | |
| 2019-12-31 | $1.40M 10-K · filed 2021-03-31 | ||
| 2018-12-31 | $3.40M 10-K · filed 2020-05-14 | $3.30M 10-K · filed 2019-03-14 | |
| 2017-12-31 | -$5.00M 10-K · filed 2019-03-14 | ||
| 2017-06-30 | $6.50M 10-KT · filed 2018-03-26 | ||
| 2016-06-30 | $8.30M 10-KT · filed 2018-03-26 | ||
| 2015-06-30 | $4.70M 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |